Cargando…
Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes
OBJECTIVE: The objective of this study was to assess long-term survival outcomes for nivolumab and everolimus in renal cell carcinoma predicted by three model structures, a partitioned survival model (PSM) and two variations of a semi-Markov model (SMM), for use in cost-effectiveness analyses. METHO...
Autores principales: | Smare, Caitlin, Lakhdari, Khalid, Doan, Justin, Posnett, John, Johal, Sukhvinder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081655/ https://www.ncbi.nlm.nih.gov/pubmed/31741315 http://dx.doi.org/10.1007/s40273-019-00845-x |
Ejemplares similares
-
Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling
por: Williams, Claire, et al.
Publicado: (2016) -
A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany
por: Watt, Maureen, et al.
Publicado: (2016) -
Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma treated in the United States
por: McCrea, Charles, et al.
Publicado: (2018) -
A Bayesian Framework for Patient-Level Partitioned Survival Cost-Utility Analysis
por: Gabrio, Andrea
Publicado: (2021) -
Dependability for systems with a partitioned state space: Markov and semi-Markov theory and computational implementation
por: Csenki, Attila
Publicado: (1994)